The stock jumped after earnings. Options now face a harder question.
Politics
The chip giant is financing the infrastructure it sells into.
A ~32% implied earnings move and a disputed “$20B backlog” are colliding with short sellers and a...
The stock trades near a decade-low valuation while the business keeps generating billions in cash.
A $9.9B Masimo deal, bioprocessing equipment orders up 30%, and the first full earnings test of the...
Industrial recovery plus AI power demand is an unusual combination for a chip company nobody was watching.
A $163B backlog and sold-out turbines through 2029 are priced in. Margin conversion is the only number...
A Meta nuclear PPA and record Q1 adjusted EBITDA are not yet in the price.
A historic Q2 beat and raised guidance just reopened the managed care trade.
BABA jumped 12% in a single session. The August earnings report is now the only thing that...
